EGFR and adenocarcinoma: More recently, Digumarthy et al. [19] demonstrated that a radiomics evaluation adds incremental value to one's clinical history and standard imaging features in predicting histology (i.e., distinguishing squamous and adenocarcinoma subtypes of nonsmall cell lung cancers) and epidermal growth factor receptor mutations.